Early Detection and Characterization of Primary Ciliary Dyskinesia
The Israeli National Consortium for Early Detection and Characterization of Primary Ciliary Dyskinesia
1 other identifier
observational
130
1 country
1
Brief Summary
Primary Ciliary Dyskinesia (PCD) is a severe genetic disorder caused by various mutations in genes affecting ciliary motility. Various new and complementary diagnostic techniques, including measurements of nasal nitric oxide (NO), Video Microscopy (VM), Immunoflourescence (IF) and genetic analysis have recently been recognized as simpler and more accurate modalities for the diagnosis and characterization of patients with PCD compared to electron microscopy. While considered a rare disease worldwide, PCD is more prevalent among highly consanguineous populations, such as those found in Israel. We hypothesize that using modern state of the art and novel test modalities on a national scale in Israel will improve diagnosis, improve phenotypic-genotypic correlations and create a national registry for PCD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2010
CompletedFirst Posted
Study publicly available on registry
February 18, 2010
CompletedStudy Start
First participant enrolled
June 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedMay 8, 2012
May 1, 2012
1.5 years
February 6, 2010
May 7, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Phenotypic and genetic characterization
2 years
Eligibility Criteria
Residents of Israel
You may qualify if:
- Patients with PCD diagnosis
- Subjects with suspected diagnosis of PCD
You may not qualify if:
- Subjects Uncooperative with study procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ziv Hospitallead
- Rambam Health Care Campuscollaborator
- Hadassah Medical Organizationcollaborator
- Tel-Aviv Sourasky Medical Centercollaborator
- Sheba Medical Centercollaborator
- Assaf-Harofeh Medical Centercollaborator
- The Nazareth Hospital, Israelcollaborator
- Soroka University Medical Centercollaborator
- Shaare Zedek Medical Centercollaborator
- Schneider Children's Medical Center, Israelcollaborator
Study Sites (1)
Ziv Medical center
Safed, 13100, Israel
Related Publications (1)
Amirav I, Mussaffi H, Roth Y, Schmidts M, Omran H, Werner C; Israeli PCD Consortium Investigators. A reach-out system for video microscopy analysis of ciliary motions aiding PCD diagnosis. BMC Res Notes. 2015 Mar 8;8:71. doi: 10.1186/s13104-015-0999-x.
PMID: 25869032DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Israel Amirav, MD
Ziv Medical Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2010
First Posted
February 18, 2010
Study Start
June 1, 2011
Primary Completion
December 1, 2012
Study Completion
June 1, 2013
Last Updated
May 8, 2012
Record last verified: 2012-05